Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 23926 AL 23940

Development and validation of a model to predict the progression of Alzheimer's disease

Chu C, Wang Y, L H Huynh A, Ng KW, Liu S, Ji G, Doecke J, Fripp J, Masters CL, Goudey B, Jin L, Pan Y.

Age Ageing. 2025 Jul 1;54(7):afaf198. doi: 10.1093/ageing/afaf198.

Eligibility for donanemab trial in a population-based study of cognitive aging

Jones KE, Aakre JA, Castillo AM, Ramanan VK, Kremers WK, Jack CR Jr, Vemuri P, Schwarz CG, Lowe VJ, Knopman DS, Petersen RC, Graff-Radford J, Vassilaki M.

J Prev Alzheimers Dis. 2025 Apr;12(4):100088. doi: 10.1016/j.tjpad.2025.100088. Epub 2025 Feb 17.

Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Trial: Genetic Resource for Precision Nutrition

Liu Y, Fowler H, Wang DD, Barnes LL, Cornelis MC.

Nutrients. 2025 Aug 4;17(15):2548. doi: 10.3390/nu17152548.

The effects of the Multicultural Healthy Diet on cognitive decline and Alzheimer's disease risk: a phase II randomized controlled trial in middle-aged adults

Mossavar-Rahmani Y, Hyun N, Hakun JG, Katz MJ, Pavlovic JM, Zetterberg H, Wang Z, Yang JB, Wylie-Rosett J, Hebert JR, Sliwinski MJ, Shaw PA.

Am J Clin Nutr. 2025 Jul;122(1):48-59. doi: 10.1016/j.ajcnut.2025.05.011. Epub 2025 May 22.

A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease

Rosenberg PB, Amjad H, Burhanullah H, Nowrangi M, Vandrey R, Pierre MJ, Outen JD, Schultz M, Marano C, Agronin M, Wilkins JM, Harper D, Laffaye T, Reardon E, Turner K, Ozonsi R, Drury M, Nguyen A, Hasoğlu T, Cromwell J, Leoutsakos JM, Forester BP.

Am J Geriatr Psychiatry. 2026 Feb;34(2):167-179. doi: 10.1016/j.jagp.2025.10.011. Epub 2025 Nov 10.

Retinal vascular alterations in cognitive impairment: A multicenter study in China

Shi Q, Ni A, Li K, Su W, Xie W, Zheng H, Wang M, Xiao Z, Wu W, Shi K, Zhang P, Yan B, Ding D, Kwok T, Zhao Q, Zhang J.

Alzheimers Dement. 2025 Feb;21(2):e14593. doi: 10.1002/alz.14593.

Japanese participant data from three gantenerumab trials in early Alzheimer's disease

Asada T, Thanasopoulou A, Delmar P, Wojtowicz J, Smith J, Yoshiyama Y, Yokoi K, Watanabe C, Isozaki M, Ozaki R, Ishida T, Tatsuda H, Tamaoka A.

Alzheimers Dement. 2025 Apr;21(4):e70192. doi: 10.1002/alz.70192.

Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study

Pascual-Lucas M, Lacosta AM, Montañés M, Canudas J, Loscos J, Monleón I, Allué JA, Sarasa L, Fandos N, Romero J, Sarasa M, Torres M, Whyms D, Terencio J, Piñol-Ripoll G, Boada M.

Alzheimers Dement. 2025 Oct;21(10):e70776. doi: 10.1002/alz.70776.

Gamma oscillation modulation for cognitive impairment: A systematic review

Bartolini E, Di Crosta A, La Malva P, Marin A, Ceccato I, Prete G, Mammarella N, Di Domenico A, Palumbo R.

J Alzheimers Dis. 2025 May;105(2):331-350. doi: 10.1177/13872877251328698. Epub 2025 Mar 28.

Brain patterns and risk factors in the FINGER RCT multimodal lifestyle intervention

Lorenzon G, Marseglia A, Mohanty R, Lehtisalo J, Poulakis K, Ngandu T, Solomon A, Kivipelto M, Westman E.

J Prev Alzheimers Dis. 2025 Dec;12(10):100390. doi: 10.1016/j.tjpad.2025.100390. Epub 2025 Sep 24.

Synapse vulnerability and resilience across the clinical spectrum of dementias

Taddei RN, Duff KE.

Nat Rev Neurol. 2025 Jul;21(7):353-369. doi: 10.1038/s41582-025-01094-7. Epub 2025 May 22.

The Alzheimer's Association clinical practice guideline for the diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer's disease and related disorders (DETeCD-ADRD): Validated clinical assessment instruments

Atri A, Dickerson BC, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M.

Alzheimers Dement. 2025 Jan;21(1):e14335. doi: 10.1002/alz.14335. Epub 2024 Dec 23.

Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease

Mendes AJ, Ribaldi F, Pievani M, Boccalini C, Garibotto V, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2025 Jun 10;104(11):e213675. doi: 10.1212/WNL.0000000000213675. Epub 2025 May 13.

The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis

Hsu CW, Hsu TW, Kao YC, Lin YH, Thompson T, Carvalho AF, Stubbs B, Tseng PT, Yang FC, Tsai CK, Yu CL, Tu YK, Liang CS.

J Prev Alzheimers Dis. 2025 Sep;12(8):100195. doi: 10.1016/j.tjpad.2025.100195. Epub 2025 May 1.

Efficacy of music therapy as a non-pharmacological measure to support alzheimer's disease patients: a systematic review

Wang J, Liu C, Dai Y, Mei C, Wang G, Wang Y, Huang T, Zhan J, Cheng J.

BMC Geriatr. 2025 Jul 8;25(1):508. doi: 10.1186/s12877-025-06073-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias